It’s Time to Transform Dementia Assessment
Nearly half of all dementia cases go undiagnosed.
The SPARK Scan is here to change that.
The Stats Are Staggering
There’s a solution
Meet the Next Generation Dementia Screener
We are SPARK Neuro, developers of the SPARK Scan, and leader in A.I.-based neurological assessment.
Developed in collaboration with The Mayo Clinic, Johns Hopkins, and MIT, the SPARK Scan combines advanced machine learning with EEG technology to accurately and objectively assess cognitive health in minutes.
That means patients get the care they need, faster. Doctors save time, focusing their efforts where they’re needed most. And payers and plans see improved diagnostic efficiency.
The SPARK Scan is:
- An FDA cleared, Class-II Device
- Simple, accurate, and non-invasive
- Available at-home or in-clinic
- Available as a full-service offering
SCreening Needs To ChANGE
The SPARK Scan Leads The Way
Most dementia screeners have a high false positive rate of 4:5, so physicians evaluate healthy people nearly half of the time.
Thanks to our very low false positive rate of 1:4, the SPARK Scan accurately identifies the right patients to focus on.
That saves time and lowers stress for physicians and patients alike.